Please see below for a list of search results.
The HTA’s high-level aims, objectives and key milestones and deliverables for 2018/19 are set out in this section. This information is supported by our key performance indicators (KPIs) and performance indicators (PIs), which set out how we will measure whether we are achieving those aims.
During 2017, the HTA undertook a fundamental review of its strategy. This exercise gave us considerable reassurance that the public and professionals think we are on the right track with our regulatory approach.
The HTA is an executive Non-Departmental Public Body sponsored by the Department of Health and Social Care, established by the Human Tissue Act 2004.
The Human Tissue Authority (HTA) has been made aware that two HTA-licensed establishments are to enter administration. These two services are Precious Cells International Ltd and